The Stanford Neuro-Oncology Program News and Events
POETIC Conference at Stanford
The POETIC conference will take place at the Koret-Taube Conference Center Stanford Institute for Economic Policy Research (SIEPR) 366 Galvez Street Stanford, CA Thursday, July 18th & Friday, July 19th.
2019 Society for Neuro-Oncology Annual Meeting
November 20 - 24, 2019
The consummate neuro-oncologist
Michelle Monje’s teenage project to aid the disabled led her to neurology and a research career that’s bringing new hope for the treatment of childhood brain cancers and the mind-fog caused by chemotherapy.
Presidential Early Career Award for Scientists and Engineers (PECASE)
Congratulations to Michelle Monje, MD, PhD on receiving the PECASE. The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional promise for leadership in science and technology.
Sixty medical students presented a broad array of projects at this year’s medical student research symposium. Med Scholars mentor, Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences, discusses how supporting students is one of her favorite aspects of the work.
This Is Your Brain on Chemo / Cell, January 10, 2019
Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.
Guided by Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences and of neurosurgery, second-year medical student Judith Pelpola investigated therapies to reduce the recurrence of glioblastoma.
Grants and Awards
2019 Clinician Educator Awards
Cynthia J. Campen, MD, MS, Clinical Associate Professor, Neurology & Neurological Sciences (Child Neurology) was awarded a 2019 Cliician Educator Award for her project titled: Characterizing White Matter Microstructure of Optic Pathways Gliomas in Children with Neurofibromatosis Type 1
2018 NIH Director’s Pioneer Award
Michelle Monje, MD, PhD is a 2018 Awardee of the NIH Director’s Pioneer Award. The Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Dr. Monje received the award based on her laboratory research which discovered that neuronal activity critically regulates the progression of glial malignancies, and now seeks to leverage a deeper understanding of neuron-glioma interactions to develop novel therapeutic strategies for these lethal brain cancers.